Remembering Harris Rosen: A life of impact
Harris Rosen gave $12 million in 2019 to advance innovative brain tumor immunotherapy research and care at UF Health. He passed away in November.
Harris Rosen gave $12 million in 2019 to advance innovative brain tumor immunotherapy research and care at UF Health. He passed away in November.
The Phase I trials to treat medulloblastoma will be led by Duane Mitchell, M.D., Ph.D., and Elias Sayour, M.D., Ph.D.
An mRNA cancer vaccine developed at the University of Florida has attracted widespread news coverage.